Dongcheng Biochem(SZ:002675) Chan Ye Xin Xi Wang·2025-11-19 01:21Core Viewpoint - The rapid aging of the population in China, with over 280 million people aged 60 and above, is driving an increase in patients with osteoarthritis and cardiovascular diseases, leading to a growing demand for chondroitin sulfate in pharmaceuticals, health supplements, and cosmetics. The market size for chondroitin sulfate in China is projected to reach approximately 1.158 billion yuan in 2024, representing a year-on-year growth of 37.69% [1][7]. Industry Overview - Chondroitin sulfate (CS) is a naturally occurring acidic polysaccharide found in animal connective tissues, crucial for maintaining cartilage elasticity, toughness, lubrication, and metabolic functions. It is composed of repeating disaccharide units and is a key component of proteoglycans [2][3]. Industry Chain - The upstream of the chondroitin sulfate industry includes terrestrial and marine biological sources, while the midstream involves the production and manufacturing of chondroitin sulfate. The downstream applications are primarily in treating joint diseases, cardiovascular diseases, and other medical fields [3][4]. Market Size - The chondroitin sulfate market in China is expected to grow to approximately 1.158 billion yuan in 2024, with a year-on-year increase of 37.69% due to the rising demand driven by an aging population and increased health awareness [1][7]. Key Companies - Leading companies in the chondroitin sulfate industry include Yantai Dongcheng Pharmaceutical, which dominates the clinical market with its chondroitin sulfate sodium product approved for treating hyperlipidemia and joint pain. Other notable companies include Shandong Haiyu Biological and Qingdao Beite, which focus on product purity and innovative production techniques [8][9]. Industry Development Trends 1. Technological Innovation: The industry is expected to see breakthroughs in biosynthesis technology, reducing reliance on animal sources and enhancing product purity through methods like microbial fermentation and supercritical extraction [10]. 2. Diversified Market Demand: The aging population will continue to drive demand for joint health supplements, with a notable shift towards high-end products in pharmaceuticals and cosmetics [11]. 3. Regulatory Standards: Stricter national policies and international standards will raise industry entry barriers, promoting the adoption of green technologies and enhancing global competitiveness [12][13].